Superficial Esophageal Cancer Clinical Trial
Official title:
A Phase III, Multicenter, Open-label Study to Evaluate the Esophageal Stenosis Inhibition Effects and Safety of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer
The purpose of this study is to evaluate the efficacy and safety of esophageal epithelial regenerative treatment by the transplantation of the product, CLS2702C, to the esophageal wound site after extensive ESD for superficial esophageal cancer.
This study is a multicenter, single-arm, open-label study of CLS2702C/D in patients who plan
to undergo ESD for superficial esophageal cancer.
In this study, the efficacy and safety of CLS2702C (cell sheet) transplanted (applied) to the
wound site after ESD using CLS2702D (transplantation device) will be evaluated.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04689594 -
A Study to Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer in the Steroid Administration Risk Group
|
Phase 3 |